MingMed
Biotech/Pharma
Series A · $243.7M
Open positions (1)
Company details
IndustryBiotech/Pharma
Funding
Total raised
$243.7M
Last stage
Series A
Investors
Total raised
$243.7M
Last stage
Series A
Investors
Zhang Yan
CEO and founder of MingMed Biotechnology, a Guangzhou-based clinical-stage biotech focused on first-in-class drug development in ophthalmology, oncology, and aesthetics.
Mingguo Huang
Co-founder of MingMed Biotechnology, founded in 2019.
Xuebin Liao
Co-founder of MingMed Biotechnology, founded in 2019.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.